
11 - 50 employees
Founded 2013
π₯ Healthcare
π Pharmaceuticals
π° $55M Series D on 2021-08
Healthcare β’ Pharmaceuticals
ARS Pharmaceuticals, Inc. is a pharmaceutical company committed to developing patient-friendly treatments to address serious issues related to needle-related risks and device ease of use. The company has introduced 'neffy,' the first and only FDA-approved needle-free epinephrine nasal spray, providing an alternative delivery method for epinephrine that is easy to carry and administer. ARS Pharma aims to make these treatments accessible and affordable through savings and support programs. The company is focused on innovative therapies that empower patients and caregivers, striving to offer practical options for epinephrine delivery.
π September 14
πΊπΈ United States β Remote
π΅ $325k - $400k / year
β° Full Time
π΄ Lead
π Vice President
π» Ghost score 5%
Where this job comes from
Posted on ARS Pharmaceuticals, Inc.'s careers page β, not through a job board
First seen by Remote Rocketship September 14
Still open on ARS Pharmaceuticals, Inc.'s site. Checked 5 hours ago.

11 - 50 employees
Founded 2013
π₯ Healthcare
π Pharmaceuticals
π° $55M Series D on 2021-08
Healthcare β’ Pharmaceuticals
ARS Pharmaceuticals, Inc. is a pharmaceutical company committed to developing patient-friendly treatments to address serious issues related to needle-related risks and device ease of use. The company has introduced 'neffy,' the first and only FDA-approved needle-free epinephrine nasal spray, providing an alternative delivery method for epinephrine that is easy to carry and administer. ARS Pharma aims to make these treatments accessible and affordable through savings and support programs. The company is focused on innovative therapies that empower patients and caregivers, striving to offer practical options for epinephrine delivery.
β’ Own clinical strategy and execution for ARS Pharmaβs allergy and urticaria portfolio β’ Lead clinical development programs from IND-enabling studies through Phase 3 registration trials β’ Lead trial design across study populations, endpoints, comparators, and statistical approaches β’ Translate medical and evidence strategy into clinical development plans, study designs, timelines, and risk/benefit tradeoffs β’ Author and oversee clinical protocols, investigator brochures, statistical analysis plans, clinical study reports, and other core clinical documents β’ Represent clinical development in interactions with FDA, EMA, and other health authorities β’ Provide medical monitoring oversight and clinical data interpretation β’ Partner with Clinical Operations and CROs to execute trials on time, on budget, and to GCP/ICH standards β’ Oversee site selection, enrollment strategy, and vendor management β’ Chair or co-chair internal safety review committees and support benefit-risk decisions and post-market clinical surveillance β’ Contribute clinical development expertise to pipeline expansion and business development opportunities β’ Partner with Medical Affairs and HEOR/RWE colleagues to generate evidence supporting adoption, guideline inclusion, and payer/reimbursement narratives β’ Engage key opinion leaders, investigators, and scientific advisory boards to inform trial design and endpoint selection β’ Represent clinical development in board meetings, investor updates, and partner/licensing discussions β’ Build, lead, and mentor a growing clinical development team
β’ MD, MD/PhD, or PharmD required β’ 12+ years of progressive clinical development leadership in the biotechnology or pharmaceutical industry β’ Significant hands-on clinical development experience in allergy, urticaria (including chronic spontaneous urticaria), or related immunology-mediated therapeutic areas β’ Demonstrated success leading clinical programs from IND through registration (BLA/NDA), including direct authorship of protocols and regulatory submissions β’ Executive presence and ability to partner effectively with the C-Suite and cross-functional leaders across Regulatory, Biometrics, Clinical Operations, Pharmacovigilance, and Commercial in a publicly traded environment β’ U.S.-based β’ Ability to travel domestically and internationally for key internal and partner meetings (up to 20β30%) β’ Experience presenting clinical data and development strategy to regulatory agencies, scientific advisory boards, and investigator/KOL audiences β’ Experience advising executive leadership on clinical development strategy, trial design, and risk/benefit tradeoffs β’ In-depth knowledge of allergy and urticaria therapeutic areas β’ Current knowledge of FDA, EMA, and global regulatory landscapes β’ Expertise in clinical trial design, including study populations, endpoint selection, comparator strategy, and adaptive/innovative trial methodologies β’ Experience managing global, multi-site clinical trials, including work with CROs and central labs β’ Ability to operate effectively in a hands-on, fast-paced environment with limited infrastructure and evolving organizational needs
β’ Performance-based incentive compensation eligibility β’ Equity β’ 401k matching β’ 100% employer-paid medical insurance for employees β’ 100% employer-paid dental insurance for employees β’ 100% employer-paid vision insurance for employees β’ Reasonable accommodation for qualified individuals with disabilities
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π September 14
Healthcare executive leading Centene's ICHRA provider network strategy and value-based contracting. Building multi-market provider networks and managing negotiations, performance, budgets, and governance.
πΊπΈ United States β Remote
π΅ $171.9k - $326.9k / year
β° Full Time
π΄ Lead
π Vice President
π September 11
Vice President of Accounting leading accounting, reconciliation, and money movement operations for PayNearMeβs enterprise payments platform. Ensuring accurate client-funds flows, controls, and GAAP-compliant reporting at scale.
πΊπΈ United States β Remote
π΅ $275k - $325k / year
π₯ Funding within the last year
π° $50M Series E - PayNearMe on 2025-09
β° Full Time
π΄ Lead
π Vice President
π September 11
Vice President of FP&A modernizing planning, forecasting, and analytics for Saviyntβs AI-powered identity security platform. Leading a 25-person finance team and scaling SaaS financial operations.
πΊπΈ United States β Remote
π° $130M Private Equity Round on 2021-09
β° Full Time
π΄ Lead
π Vice President
π¦ H1B Visa Sponsor
π September 11
VP of Finance leading FP&A, IPO readiness, and capital planning at Sidecar Health. Shaping financial strategy for a mission-driven U.S. health insurance company.
π September 11
Vice President leading Med-Metrixβs hospital revenue-cycle denials prevention transformation. Driving analytics, payer strategies, and operational change to protect revenue and improve clean-claim performance.
πΊπΈ United States β Remote
π° Private equity on 2025-09
β° Full Time
π΄ Lead
π Vice President